Remove 2027 Remove Documentation Remove Medical Records
article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

FDA Law Blog: Biosimilars

FDA believes that RWE has the power to “accelerate medical product development and bring new innovations and advances faster and more efficiently to the patients who need them, without compromising patient safety.” This guidance, when finalized, will replace the original version of this document finalized in 2017.